@dansfera: Ever wondered if the glorious world of FSP models in clinical research is as transparent as it seems? There’s a hidden game behind those commoditized services that most people overlook. While many view these models as a way to cut out excessive markups, the reality of how these contracts are actually won—like the brutal arena of reverse auctions—tells a much different story. It’s a classic loss leader strategy in disguise. This take really pulls back the curtain on the uncomfortable truth about CRO pricing dynamics. #ClinicalResearch #CRO #PharmaIndustry #FSP #BusinessStrategy